Nextleaf Solutions now has eight issued patents for cannabis extraction after latest awards

The Vancouver-headquartered firm's patents all relate to the production of high-purity, cannabinoid rich distillate

Nextleaf Solutions -
There is significant shareholder value creation through the formalization and protection of intellectual property (IP), the group said

Nextleaf Solutions Ltd (CSE:OILS) (OTCMKTS:OILFF) told investors it had been awarded its fifth US patent, one of three new ones it has received, bringing its intellectual property (IP) portfolio to eight issued patents.

The Vancouver-headquartered firm's patents all relate to the production of high-purity, cannabinoid-rich distillate, which is the key ingredient used in making THC and CBD infused products and the latest US one relates to post-extraction processing.

READ: Nextleaf Solutions and BevCanna Enterprises team up to bring cannabis-infused beverages to consumers

This stage includes the filtration and targeted removal of pigments – all of which create greater efficiencies and higher throughput rates.

Nextleaf also received positive news on two patents issued from the Canadian Intellectual Property Office as well as from Intellectual Property Australia.

"As we've seen with transactions like Canopy Growth Corp's US$330 million acquisition of Ebbu Inc. and its portfolio of pending patents, there is significant shareholder value creation through the formalization and protection of intellectual property," remarked Paul Pedersen, Nextleaf Solutions' CEO.

"The difficulties cannabis companies have faced in turning intellectual property into patents point to a broader issue in the industry, where many companies tout their intellectual property, but few have successfully obtained exclusive rights to their inventions.

"Nextleaf being granted eight patents by three international patent offices in key markets such as Canada, Australia, and the United States validates our technology and further reinforces our vision to develop disruptive intellectual property for industrial-scale extraction, purification and formulation of cannabinoids."

The company also told investors that it remained focused on expanding its IP portfolio by developing and acquiring the industry's most advanced and scalable cannabis processing solutions.

Potential to reduce costs

By applying its IP, Nextleaf has the potential to vastly reduce the cost of CBD and THC oil production, it highlighted.

Earlier this week, it emerged that Nextleaf and BevCanna Enterprises Inc (CSE:BEV) are teaming up to bring cannabis-infused beverages to Canadian shelves.

In a statement, Nextleaf said it had granted BevCanna exclusive license to its intellectual property related to water-soluble cannabinoids to develop, manufacture and sell BevCanna’s infused cannabis beverage brands.

The agreement includes BevCanna’s in-house brands and white label products developed for third parties, the companies said.

Shares in Toronto advanced 5.32% to stand at C$0.50 each.

---Updates for share price---

Contact the author at giles@proactiveinvestors.com


Price: 0.19 CAD

Market: CSE
Market Cap: $22.69 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of NEXTLEAF SOLUTIONS Ltd. named herein, including the promotion by the Company of NEXTLEAF SOLUTIONS Ltd. in any Content on the Site, the Company...


Nextleaf completes successful scale trials for Rapid Emulsion Technology by OILS

Nextleaf Solutions (CSE: OILS) Director of Marketing Emma Andrews joined Steve Darling from Proactive to discuss the company’s completion of their successful scale trials using their Rapid Emulsion Technology by OILS. Andrews discussed how that technology sets Nextleaf apart and how they can...

3 weeks, 1 day ago

2 min read